Adwe Prenatal Vitamin Recalled for Folic Acid Potency Concerns
DNE Nutraceuticals Inc. is recalling Adwe Prenatal tablets due to a concern regarding the potency of folic acid. The recall affects 1,200 bottles distributed in New York.
The agency’s classification
FDA (Food): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a potency concern (under-dosing) rather than a high-risk pathogen or acute injury, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
DNE Nutraceuticals Inc. is recalling Adwe Prenatal tablets, manufactured for Adwe Laboratories, due to a concern regarding the potency of folic acid. The product is identified by Lot 8990 and UPC 040168805079.
The recall involves 1,200 bottles of the product. Distribution was limited to New York. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers who have purchased this product should stop using it and contact the recalling firm for further instructions or a refund.
The recalled product
- Product
- Adwe Naturals Prenatal Vitamin Manufactured for: Adwe Laboratories 1274 49 Street Brooklyn, NY 11219 UPC 040168805079
- Manufacturer
- DNE Nutraceuticals Inc.
- Category
- Drug — Dietary Supplement
- Hazard
- Affected units
- 1,200
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot 8990
Distribution
Distributed in 1 state:
Related recalls
Same hazard · potency concern
See all →- HighEquate Tartar Control Plus Mouthwash Recalled for Out-of-Specification Formula
FDA (Drugs) · 2022-06-08
Other drug recalls
- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Failures
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- High
- HighNordic Naturals Baby Vitamin D3 Liquid Recalled for Elevated Levels
FDA (Food) · 2024-04-03
- SevereFDA Recalls Vitamin D3 Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-03
- LowVirtPrex Prenatal Tablets Recalled Due to API Manufacturer Import Alert
FDA (Drugs) · 2017-01-04
- LowVirt-Advance Prenatal Softgels Recalled Due to API Manufacturer Import Alert
FDA (Drugs) · 2017-01-04
- ModerateNew Generation Wellness Recalls Vegan Vitamin D3 Tablets for Stability Issues
FDA (Food) · 2021-04-14